Epigenetic Mechanisms in Monocytes/Macrophages Regulate Inflammation in Cardiometabolic and Vascular Disease

Area of Science:

• Immunology
• Epigenetics
• Cardiovascular Science

Background:

• Cardiometabolic and vascular diseases are leading causes of death, driven by chronic inflammation.
• Monocytes and macrophages are central to inflammatory processes underlying cardiovascular disease.
• Epigenetic modifications, including DNA methylation and histone processing, are increasingly recognized as regulators of immune cell function.

Purpose of the Study:

• To review the current understanding of monocyte/macrophage polarization.
• To highlight the role of epigenetic modifications in regulating monocyte/macrophage phenotype.
• To discuss the implications in obesity, diabetes mellitus, atherosclerosis, and abdominal aortic aneurysms.

Main Methods:

• Literature review of studies on epigenetics and monocyte/macrophage function.
• Analysis of epigenetic enzyme roles in immune cell signaling.
• Synthesis of findings related to cardiometabolic and vascular diseases.

Main Results:

• Epigenetic enzymes dynamically regulate monocyte/macrophage signaling pathways.
• These modifications alter immune cell phenotypes in response to environmental cues.
• Epigenetic regulation is implicated in the pathogenesis of major cardiometabolic and vascular conditions.

Conclusions:

• Epigenetic modifications are critical regulators of monocyte/macrophage phenotype.
• Targeting epigenetic mechanisms may offer novel therapeutic strategies for cardiovascular diseases.
• Further research into epigenetic regulation is essential for understanding and treating cardiometabolic diseases.